Mpro–N3 experimental complex
The 6LU7 entry contains SARS-CoV-2 main protease bound to the inhibitor N3. Inspect the full experimental structure in the interactive viewer above.
Open RCSB 3D viewer ↗Ligandly brings together research tools, methods, and visualization resources for studying protein–ligand interactions. Explore the science, then open the analysis applications.
Structures, ligands, and analysis parameters
Use a connected research application
Review molecular evidence and limitations
The structure can still be examined at RCSB PDB.
Experimental crystal structure of Mpro in complex with the covalent inhibitor N3.
Browse research methods and tool access points. Only verified applications should be linked as live services.
Investigate predicted binding poses and compare computational hypotheses.
Examine molecular contacts, residue environments, and interpretation limits.
Inspect macromolecular structures in an interactive scientific viewer.
Understand inputs, outputs, assumptions, and reproducible reporting.
This example uses a single experimentally determined structure, PDB 6LU7, with its co-crystallized inhibitor N3. It does not represent a docking result produced by Ligandly.
The 6LU7 entry contains SARS-CoV-2 main protease bound to the inhibitor N3. Inspect the full experimental structure in the interactive viewer above.
Open RCSB 3D viewer ↗N3 is the ligand associated with this experimental complex. It is not caffeine and is not a ligand independently docked by Ligandly.
Review ligand in source entry ↗| PDB ID | 6LU7 |
|---|---|
| Method | X-ray diffraction |
| Resolution | 2.16 Å |
| Bound inhibitor | N3 |
| Source | RCSB PDB |
Scientific provenance: PDB 6LU7. For reproducible analysis, download the experimental coordinate file from RCSB. No binding-affinity or docking score is asserted here.